Scinai Immunotherapeutics Ltd. (SCNI) Insider Trading Activity

NASDAQ$0.4511-0.02 (-4.24%)
Market Cap
$243,943.00
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
759 of 849
Rank in Industry
437 of 491

SCNI Insider Trading Activity

SCNI Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
–
Sells
$0
0
–

Related Transactions

About Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd. operates as an emerging biopharmaceutical company, dedicated to the research, production, and market introduction of medical solutions. Based in Israel, its primary objective is the prevention and treatment of a range of infectious, autoimmune, and other health conditions. The company maintains a significant licensing and collaboration agreement with the Max Planck Society and the University Medical Center Göttingen. This partnership is focused on advancing and commercializing a nanosized antibody (NanoAb) …

Insider Activity of Scinai Immunotherapeutics Ltd.

Over the last 12 months, insiders at Scinai Immunotherapeutics Ltd. have bought $0 and sold $0 worth of Scinai Immunotherapeutics Ltd. stock.

On average, over the past 5 years, insiders at Scinai Immunotherapeutics Ltd. have bought $0 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

List of Insider Buy and Sell Transactions, Scinai Immunotherapeutics Ltd.

2005-09-28SaleBARRON PARTNERS LP10 percent owner
547,323
8.5802%
$0.46
$251,769
2005-09-26SaleBARRON PARTNERS LP10 percent owner
5,000
0.0852%
$0.50
$2,500
2005-09-23SaleBARRON PARTNERS LP10 percent owner
5,000
0.0869%
$0.51
$2,550
Total: 3

SCNI Institutional Investors: Active Positions

Increased Positions4+57.14%50,375+104.66%
Decreased Positions3-42.86%16,558-34.4%
New Positions2New42,703New
Sold Out Positions<1Sold Out14,696Sold Out
Total Postitions8+14.29%81,949+70.26%

SCNI Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Citadel Advisors Llc$21.000%28,630+17,031+146.83%2025-09-30
Two Sigma Securities, Llc$11.000%14,696+14,696New2025-09-30
Rhumbline Advisers$3.000%3,553+70+2.01%2025-09-30
Northwestern Mutual Wealth Management Co$1.000%1,000+1,000New2025-09-30
Morgan Stanley$00%245-10-3.92%2025-09-30
Ubs Group Ag$00%8-12,048-99.93%2025-09-30
Credit Agricole S A$00%0-42Sold Out2025-09-30
Bank Of Montreal /Can/$00%0-10,000Sold Out2025-09-30
Yorkville Advisors Global, Lp$00%0-42,000Sold Out2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.